Nicotine & The Vaping Era

Introduction

Biological Basis

Genetic predisposition accounts for 40-60% of the vulnerability to addiction, highlighting its nature as a medical condition.

Environmental Influence

Factors like early exposure, trauma, and socioeconomic conditions play critical roles in the development of SUD.

Tobacco use remains the leading preventable cause of death worldwide, killing 8 million people annually. Yet as traditional cigarette smoking has declined in many countries, a new phenomenon has emerged: electronic cigarettes and vaping devices. This module examines nicotine addiction across delivery systems—from combustible tobacco to modern vaporizers—and the unique public health challenges posed by e-cigarettes.

Learning Objectives

By the end of this module, you will be able to:

Explain the neurobiological basis of nicotine addiction
Compare delivery systems: combustible, smokeless, and electronic
Identify the unique risks of vaping, including EVALI
Analyze marketing strategies targeting youth
Apply cessation strategies appropriate to different products

Nicotine: The Addictive Agent

Pharmacology

Mechanism of Action:

Nicotine binds to nicotinic acetylcholine receptors (nAChRs)
Primary target: α4β2 subtype in VTA
Stimulates dopamine release to nucleus accumbens
Also affects glutamate, GABA, serotonin, norepinephrine
Produces alertness, concentration, mood elevation, appetite suppression

Pharmacokinetics:

Smoking: Peak brain levels in 10-20 seconds
Vaping: Similar to smoking (depends on device)
Nicotine patch: Peak in 4-8 hours
Nicotine gum: Peak in 20-30 minutes

Key Point: The speed of nicotine delivery determines addictive potential. Faster delivery = more reinforcing = more addictive.

Tolerance and Withdrawal

Rapid Tolerance:

Receptors desensitize within minutes
Upregulation occurs with chronic use
Results in narrowing "window" of satisfying use
Morning craving due to overnight resensitization

Withdrawal Symptoms (onset 2-12 hours):

Irritability, anxiety, restlessness
Difficulty concentrating
Increased appetite, weight gain
Depressed mood
Sleep disturbances
Intense craving

Timeline:

Peak: 24-72 hours
Duration: 2-4 weeks for most physical symptoms
Cravings: May persist for months

Evolution of Nicotine Delivery Systems

Traditional Combustible Tobacco

Products: Cigarettes, bidis, hookah, cigars

Mechanism: Tobacco combustion produces smoke containing:

Nicotine (the addictive agent)
Tar (particulate matter, carcinogens)
Carbon monoxide (cardiovascular harm)
7,000+ chemicals, 70+ known carcinogens

Health Consequences:

Lung cancer (15x increased risk)
COPD (Chronic Obstructive Pulmonary Disease)
Cardiovascular disease
Stroke
Multiple other cancers
Premature death (10 years life expectancy reduction)

Smokeless Tobacco

Products: Chewing tobacco, gutka, paan with tobacco, snuff, snus

Prevalence in India:

21.4% of adults use smokeless tobacco
Higher in rural areas
Cultural integration (paan tradition)
Often perceived as "safer" than smoking

Health Consequences:

Oral cancers (significantly elevated risk)
Oral leukoplakia (pre-cancerous lesions)
Gum disease, tooth loss
Cardiovascular effects (though lower than smoking)
Pancreatic cancer
Pregnancy complications

Indian Context: Smokeless tobacco causes a disproportionate burden of oral cancer in India, which has among the highest rates globally.

Electronic Nicotine Delivery Systems (ENDS)

Products: E-cigarettes, vape pens, pod systems, mods

Technology:

Battery heats element
Element vaporizes e-liquid
E-liquid contains: nicotine, propylene glycol, vegetable glycerin, flavorings
User inhales aerosol (not smoke)
No combustion = no tar, less carbon monoxide

Nicotine Delivery:

Modern devices deliver nicotine as efficiently as cigarettes
Nicotine salts (used in JUUL) allow high concentrations without harshness
Some pods contain 5% nicotine (equivalent to ~20 cigarettes)

The E-Cigarette Controversy

Potential Benefits (Harm Reduction Argument)

For Adult Smokers:

Eliminates combustion (primary source of harm)
May aid smoking cessation (evidence mixed)
Reduced exposure to carcinogens (compared to cigarettes)
Some users successfully transition away from cigarettes

Public Health England Position:

Estimates e-cigarettes are "95% less harmful" than cigarettes
Recommends as cessation tool for adult smokers
Emphasizes relative harm, not absolute safety

Serious Concerns

Youth Epidemic:

E-cigarette use among youth increased 900% (2011-2015, US data)
Flavors (mango, mint, candy) appeal to adolescents
Sleek, concealable designs (looks like USB drive)
Social media marketing
"Gateway" concern: May lead to cigarette use

Unknown Long-Term Effects:

E-cigarettes too new for long-term data
Inhalation of propylene glycol, flavorings over years?
Heavy metals from heating coils
Ultrafine particles reach deep lung

Dual Use:

Many e-cigarette users also smoke cigarettes
May not reduce harm if not complete substitution
May delay quit attempts

Nicotine Effects on Adolescent Brain:

Adolescent brain particularly vulnerable
Nicotine affects PFC development
May increase risk of mood disorders
May "prime" brain for other addictions

EVALI: E-cigarette/Vaping Product Use-Associated Lung Injury

The 2019 Outbreak

What Happened:

Cluster of severe lung injuries reported August 2019
Rapidly escalated: 2,800+ cases, 68 deaths (US)
Primarily young, previously healthy individuals
Symptoms: Cough, shortness of breath, chest pain, fever, GI symptoms

Investigation Findings:

Strongly linked to THC-containing vape products
Vitamin E acetate identified as primary culprit
Added as cutting agent in illicit THC cartridges
When heated, causes lipoid pneumonia

Symptoms of EVALI:

Respiratory: Cough, shortness of breath, chest pain
Constitutional: Fever, chills, weight loss
Gastrointestinal: Nausea, vomiting, diarrhea
Onset: Days to weeks after use

Clinical Approach:

High index of suspicion in e-cigarette users with respiratory symptoms
Chest imaging (ground-glass opacities)
Rule out infectious causes
Consider hospitalization for moderate-severe cases
Supportive care, corticosteroids in some cases

Key Message: EVALI primarily associated with THC products and additives, but underscores that e-cigarettes are not without acute risk.

Marketing and Youth Targeting

Industry Tactics

Flavors:

15,000+ e-liquid flavors available
Fruit, candy, dessert flavors appeal to youth
Mint/menthol remained popular after other flavors restricted

Social Media:

Influencer marketing on Instagram, TikTok
User-generated content
"Vape tricks" videos normalize use
Hashtag campaigns

Design:

Sleek, tech-like appearance
Easily concealed (looks like USB)
Customizable, collectible

Messaging:

"Healthier alternative"
"No tobacco smell"
"Freedom" and "rebellion" themes
Association with lifestyle/identity

Regulatory Response

United States:

Raised federal tobacco age to 21 (2019)
Banned flavored cartridge-based e-cigarettes (2020, with exceptions)
Required pre-market authorization
Enforcement actions against targeting youth

India:

Complete ban on e-cigarettes (September 2019)
Prohibition on production, import, sale, storage, advertisement
Includes ENDS, ENNDS, heat-not-burn products
Concerns about youth uptake drove policy

European Union:

Nicotine concentration limits (20mg/ml)
Tank size limits (2ml)
Health warning requirements
Advertising restrictions

Nicotine Addiction Treatment

Pharmacotherapy

Nicotine Replacement Therapy (NRT):

| Product | Delivery | Duration | Notes | |---------|----------|----------|-------| | Patch | Transdermal | 16-24 hours | Steady state, prevents withdrawal | | Gum | Buccal | PRN | Addresses acute craving | | Lozenge | Oral | PRN | Discreet, no chewing required | | Inhaler | Oral | PRN | Hand-to-mouth habit replacement | | Nasal Spray | Nasal | PRN | Fastest NRT delivery |

Prescription Medications:

Varenicline (Chantix/Champix):

Partial agonist at α4β2 nAChR
Reduces craving and withdrawal
Blocks rewarding effects of nicotine
Most effective single agent
12-week course typical

Bupropion (Wellbutrin/Zyban):

Norepinephrine-dopamine reuptake inhibitor
Reduces craving and withdrawal
Also used for depression
Start 1-2 weeks before quit date

Behavioral Interventions

Brief Advice (5 A's):

Ask about tobacco use
Advise to quit in clear, personalized manner
Assess willingness to quit
Assist with quit plan, pharmacotherapy
Arrange follow-up

Intensive Counseling:

Individual or group therapy
Identify triggers, develop coping
Relapse prevention
Quitlines (telephone support)
Text message programs

Combination Approaches

Most effective: Pharmacotherapy + Behavioral Support

Evidence-Based Combinations:

Long-acting NRT (patch) + short-acting NRT (gum/lozenge)
Varenicline + NRT (in some cases)
Medication + intensive counseling

Quit Rates (6-12 months, approximate):

Unaided: 3-5%
Brief advice only: 5-10%
Single NRT: 15-20%
Varenicline: 25-35%
Combination therapy: 30-40%

Special Populations

Pregnant Women

Nicotine is teratogenic (restricts blood flow, affects fetal development)
Complete cessation is goal
Behavioral counseling first-line
NRT considered if behavioral fails (lower risk than smoking)
E-cigarettes NOT recommended in pregnancy

Mental Health Conditions

Smoking rates 2-4x higher in mental health populations
Tobacco may interact with psychiatric medications
Cessation can improve mental health (contrary to fears)
Adjust medication doses when quitting (reduced hepatic enzyme induction)

Dual Users (Cigarettes + E-cigarettes)

Complete substitution needed for harm reduction benefit
Support transition away from combustibles
Eventually, support complete nicotine cessation if desired

Case Study: The Vaping Teenager

Anika, 16, is brought by her parents after they discovered she has been vaping for 8 months. She started with friends who shared their JUUL devices. She now vapes daily, often in school bathrooms, and becomes irritable if unable to vape for several hours. She says, "It's not like smoking—it's just water vapor."

Discussion Questions:

4How would you explain the risks of vaping to Anika in age-appropriate terms?
5What neurobiological concerns exist for adolescent nicotine exposure?
6How would you approach cessation with a teenager?
7What role should her parents play?
8How would you address her misconception that e-cigarettes are "just water vapor"?

Key Takeaways

Nicotine is highly addictive due to rapid delivery to brain and receptor dynamics
Combustible tobacco remains the most harmful, but no nicotine delivery system is risk-free
E-cigarettes may reduce harm for adult smokers but pose serious concerns for youth
EVALI demonstrated acute risks, primarily from THC/vitamin E acetate products
India has banned e-cigarettes; smokeless tobacco remains a major challenge
Combination pharmacotherapy + counseling is most effective for cessation
Youth prevention and adult cessation require different strategies

Next Module: Depressants: Alcohol & Sedatives →